Supply of FDA-Approved Blood Typing IVD Reagents (Werfen Gamma N-HANCE Line)

The contract seeks the supply of FDA-approved in vitro diagnostic reagents specifically designed for automated blood typing on the Werfen Gamma N-HANCE platform, to be distributed across all Veterans Integrated Service Network 22 VA medical centers. These reagents are critical for accurate and efficient blood typing procedures in clinical settings, ensuring patient safety and operational readiness within the VA healthcare system. The procurement is structured as a subcontract, with NAICS Code 325414 indicating classification under Medical Equipment and Supply Manufacturing, and the offering is issued by the Department of Veterans Affairs through the 262-NETWORK Contract Office 22. The solicitation was posted on May 5, 2026, with a response deadline of May 20, 2026 at 2:00 p.m. Eastern Time, requiring vendors to submit proposals within this window to be considered. While no set-aside provisions are specified, the place of performance covers all VA facilities within VISN 22, which includes medical centers across a defined geographic region, likely requiring reliable logistics and inventory management to support distributed distribution. The contract focuses exclusively on compatible reagents for the Werfen Gamma N-HANCE system, ensuring standardization and seamless integration with existing automated platforms at the installations.